Home  >  Products  >  NCAM1 (neural cell adhesion molecule 1) Blocking Peptide (the C terminal of NCAM1)(100ug)
NCAM1 (neural cell adhesion molecule 1) Blocking Peptide (the C terminal of NCAM1)(100ug)

NCAM1 (neural cell adhesion molecule 1) Blocking Peptide (the C terminal of NCAM1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-NCAM1 Antibody (ARP59939_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP59939
Size: 100ug
Weight: 39kDa
Gene: 6010
Format: Lyophilized powder
Target: Retinitis pigmentosa is an inherited progressive disease which is a major cause of blindness in western communities. It can be inherited as an autosomal dominant, autosomal recessive, or X-linked recessive disorder. In the autosomal dominant form,which comprises about 25% of total cases, approximately 30% of families have mutations in the gene encoding the rod photoreceptor-specific protein rhodopsin. This is the transmembrane protein which, when photoexcited, initiates the visual transduction cascade. Defects in this gene are also one of the causes of congenital stationary night blindness.
Alternative names: CSNBAD1; MGC138309; MGC138311; OPN2; RP4
See Full Product Listings >